Loading clinical trials...
Loading clinical trials...
The purpose of this study was to evaluate the effect of 4-week SPN-810 treatment on brain functioning in patients aged 8-12 years with ADHD and associated feature of impulsive aggression (IA). This wa...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Supernus Pharmaceuticals, Inc.
NCT06810180 · Attention Deficit Hyperactivity Disorder (ADHD), Sleep, and more
NCT07189442 · Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD)
NCT07180758 · Attention Deficit Hyperactivity Disorder (ADHD)
NCT07459699 · Attention Deficit Hyperactivity Disorder (ADHD)
NCT04943796 · Attention Deficit Hyperactivity Disorder (ADHD)
Meridien Research aka Florida Clinical Research Center, LLC
Lakeland, Florida
Florida Clinical Research Center, LLC.
Maitland, Florida
University of South Florida- Dept. of Psychiatry and Neurosciences
Tampa, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions